Catholic Uijeongbu St. Mary's Hospital Earns Grade 1 as Leading Breast Cancer Treatment Center in Northern Gyeonggi

Catholic University Uijeongbu St. Mary's Hospital has received the highest rating, Grade 1, in the "Second Cycle, First Breast Cancer Adequacy Assessment (assessment period: January to December 2023)" announced by the Health Insurance Review & Assessment Service. The hospital achieved a comprehensive score of 96.3 points, significantly surpassing the national average of 88.13 points and the average for similar hospitals, which was 88.0 points.

Catholic University Uijeongbu St. Mary's Hospital exterior. Provided by Uijeongbu St. Mary's Hospital

The Health Insurance Review & Assessment Service has been conducting breast cancer adequacy assessments since 2012. This year's evaluation comprehensively reflected eight criteria, including the composition of specialized personnel, the rate of multidisciplinary care, the rate of surgeries performed within 30 days, the rate of patient education and counseling, surgical mortality rate, and readmission rate. Uijeongbu St. Mary's Hospital achieved a perfect score of 100% in all areas, including the composition of specialized personnel, cancer patient education and counseling, completeness of pathology reporting, and the rate of radiation therapy performed.

A representative from Catholic University Uijeongbu St. Mary's Hospital stated, "This Grade 1 rating for breast cancer is the result of providing high-quality cancer treatment services to patients in the northern Gyeonggi region," and added, "We will continue to do our best as a leading regional cancer treatment center to ensure patient safety and improve treatment outcomes."

This content was produced with the assistance of AI translation services.